Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Malignant Melanoma

Free Subscription 26.01.2026 3 Ann Surg Oncol 1 Biochem Biophys Res Commun 1 Cancer 1 Cancer Res 2 J Am Acad Dermatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. RIAZ N, Leong SP, Kashani-Sabet M, White RL Jr, et al
   Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.
   Ann Surg Oncol. 2026 Jan 23. doi: 10.1245/s10434-026-19086.
   PubMed         Abstract available
   
   
2. NOVIS E, Rautalin M, Amaria RN, Ascierto PA, et al
   ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.
   Ann Surg Oncol. 2026 Jan 23. doi: 10.1245/s10434-025-19025.
   PubMed        
   
   
3. CHAKRABORTY NN, Bhatty M, Zablonski KG, Boone JM, et al
   ASO Visual Abstract: Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?
   Ann Surg Oncol. 2026 Jan 22. doi: 10.1245/s10434-026-19097.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

4. ZHU Q, Zhao M, Guo W, Wang H, et al
   MPC1 deficiency promotes melanoma progression via Wnt/beta-catenin signaling.
   Biochem Biophys Res Commun. 2026;801:153310.
   PubMed         Abstract available
   
   

   
   Cancer

5. DILEO M, Oglesby S, Leung CH, Pauken KE, et al
   Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele.
   Cancer. 2026;132:e70262.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
   CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
   Cancer Res. 2026;86:438-452.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

7. PIETKIEWICZ P, Voloshynovych M, Anriot J, Koper M, et al
   Ochre fluorescence under ultraviolet-induced fluorescence dermatoscopy is a strong clue to melanoma - results of an international retrospective cross-sectional study.
   J Am Acad Dermatol. 2026 Jan 21:S0190-9622(26)00057.
   PubMed        
   
   
8. RIBAUDO I, Homer A, Xiang L, Arbesman J, et al
   Malpractice Litigation in Melanoma: Analysis of the LexisNexis Legal Database, 2000-2024.
   J Am Acad Dermatol. 2026 Jan 16:S0190-9622(26)00013.
   PubMed        
   
   

   
   PLoS One

9. PAJAREEYAPHAN S, Thongsuksai P, Sriplung H, Wichaidit W, et al
   Trends in skin cancer incidence in Songkhla, Southern Thailand, 1989-2020: A population-based study on the impact of geographic variation.
   PLoS One. 2026;21:e0331635.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.